ACD	acid citrate dextrose
ADL	activities of daily living
ADP	adenosine diphosphate
A-PRF	advanced-platelet-rich fibrin
ACP	autologous conditioned plasma
BMSCs	bone marrow stem cells
BMP	bone morphogenic protein
CTAD	citrate-theophylline-adenosine-dipyridamole
ct	conventional treatment
CS	Corticosteroid
DP	dextrose prolotherapy
DEPA	dose of platelet efficiency, purity and activation
EGF	epidermal growth factor
EDTA	ethylene diamine tetra-acetic acid
ESWT	extracorporeal shock wave therapy
FG	fibroblast growth factor
GFs	growth factors
HO	heme oxygenase
HS	heparin sodium
HVI	high volume injection
HA	hyaluronic acid
IGF	insulin-like growth factor
ISTH	International Society on Thrombosis and Haemostasis
KT	kinesio therapy
KOOS	knee injury and osteoarthritis outcome score
LE	lateral epicondyle
L-PRF	leukocyte- and platelet-rich fibrin
LP-PRP	leukocyte-poor PRP
L-PRP	leukocyte-rich PRP
LR-PRP	leukocyte-rich PRP
MRI	magnetic resonance imaging
MSC	mesenchimal stem cells
MARSPILL	method, activation, red blood cells, spin, platelets, image guidance, leukocytes and light activation
MIF	migration inhibitory factor
OA	osteoarthritis
PAW	photoactivated
PDWHF	platelet-derived wound healing factors or formula-
PF	plantar fasciopathy
PRFM	platelet-rich fibrin matrix
PRGF	plasma rich in growth factors
PAW	platelet activation, white blood cells
PCs	platelet concentrates
PLRA	platelet leukocyte red blood cells and activation
PRP	platelet rich-plasma
PDGF	platelet-derived growth factor
PPP	platelet-poor plasma
PRF	platelet-rich fibrin
P-PRF	pure platelet-rich fibrin
QoL	quality of life
RBCs	red blood cells
SC	sodium citrate
t-PRP	temperature controlled PRP
TGF	transforming growth factor
US	ultra-sound
VEGF	vascular endothelial growth factor
VAS	visual analogue scale
WOMAC	the Western Ontario and McMaster Universities Osteoarthritis Index